• 

  December 3, 2024

  EpiBone Secures Funding Convertible Note to Drive Global Expansion of Clinical Trials

  R.D. Solorzano

• 

  December 2, 2024

  Engineering the Future of Vascularized Tissues: Programmable Bioinks Take Center Stage

  R.D. Solorzano

• 

  December 2, 2024

  Carl Roth Partners with BIO INX to Advance 3D Bioprinting Accessibility

  R.D. Solorzano

• 

  November 27, 2024

  French Based Lattice Medical Wins Coveted US MedTech Innovator Mid-Stage Grand Prize

  R.D. Solorzano

• 

  November 26, 2024

  CELLINK’s Strategic Shift: Right-Sizing for Long-Term Profitability

  R.D. Solorzano

• 

  November 25, 2024

  Cellbricks Therapeutics Expands to the U.S., Launches Subsidiary in Cambridge, MA

  R.D. Solorzano

• 

  November 22, 2024

  HITS-Bio: High-Throughput Bioprinting for Scalable Tissue Fabrication

  R.D. Solorzano

• 

  November 22, 2024

  BICO Divests Nanoscribe: A Strategic Shift Towards Life Sciences

  R.D. Solorzano

• 

  November 13, 2024

  Xolo Unveils Xell: An Affordable Volumetric Bioprinter for Labs

  R.D. Solorzano

• 

  November 12, 2024

  Unveiling the Impact of Hypodermis on Gene Expression in 3D Bioprinted Skin Models

  R.D. Solorzano